{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T19:44:55Z","timestamp":1783539895834,"version":"3.55.0"},"reference-count":52,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["cghjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Gastroenterology and Hepatology"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/j.cgh.2023.03.025","type":"journal-article","created":{"date-parts":[[2023,3,31]],"date-time":"2023-03-31T03:48:44Z","timestamp":1680234524000},"page":"2901-2907.e2","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Effectiveness of Hepatitis B Vaccination for Patients With Inflammatory Bowel and Celiac Disease"],"prefix":"10.1016","volume":"21","author":[{"given":"Jessica A.","family":"Ulrich","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nawras W.","family":"Habash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasmine A.","family":"Ismail","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William J.","family":"Tremaine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy L.","family":"Weaver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph A.","family":"Murray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"Edward V.","family":"Loftus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7565-870X","authenticated-orcid":false,"given":"Imad","family":"Absah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cgh.2023.03.025_bib1","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.14309\/ajg.0000000000000651","article-title":"Prevalence of chronic hepatitis B virus infection in the United States","volume":"115","author":"Lim","year":"2020","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2023.03.025_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr6701a1","article-title":"Prevention of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices","volume":"67","author":"Schillie","year":"2018","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.cgh.2023.03.025_bib3","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1093\/infdis\/jiw142","article-title":"A\u00a0longitudinal hepatitis B vaccine cohort demonstrates long-lasting hepatitis B virus (HBV) cellular immunity despite loss of antibody against HBV surface antigen","volume":"214","author":"Simons","year":"2016","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.cgh.2023.03.025_bib4","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1093\/ibd\/izaa353","article-title":"Hepatitis-B vaccine response in inflammatory bowel disease patients: a systematic review and meta-analysis","volume":"27","author":"Kochhar","year":"2021","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.cgh.2023.03.025_bib5","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1111\/apt.16880","article-title":"Meta-analysis: hepatitis B vaccination in inflammatory bowel disease","volume":"55","author":"Singh","year":"2022","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cgh.2023.03.025_bib6","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1093\/ibd\/izaa055","article-title":"Optimizing immunization strategies in patients with IBD","volume":"27","author":"Caldera","year":"2021","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.cgh.2023.03.025_bib7","doi-asserted-by":"crossref","first-page":"2633","DOI":"10.1016\/j.vaccine.2017.03.080","article-title":"Immune response to hepatitis B vaccination among people with inflammatory bowel diseases: a systematic review and meta-analysis","volume":"35","author":"Jiang","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.cgh.2023.03.025_bib8","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1111\/j.1572-0241.2003.07701.x","article-title":"Hepatitis B vaccine nonresponse and celiac disease","volume":"98","author":"Noh","year":"2003","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2023.03.025_bib9","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1097\/MPG.0b013e3180320654","article-title":"Failure to respond to hepatitis B vaccine in children with celiac disease","volume":"44","author":"Park","year":"2007","journal-title":"J\u00a0Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.cgh.2023.03.025_bib10","doi-asserted-by":"crossref","first-page":"838","DOI":"10.3748\/wjg.v19.i6.838","article-title":"Hepatitis B vaccine in celiac disease: yesterday, today and tomorrow","volume":"19","author":"Vitaliti","year":"2013","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.cgh.2023.03.025_bib11","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.4254\/wjh.v8.i26.1105","article-title":"Immune response to hepatitis B virus vaccine in celiac subjects at diagnosis","volume":"8","author":"Filippelli","year":"2016","journal-title":"World J Hepatol"},{"key":"10.1016\/j.cgh.2023.03.025_bib12","doi-asserted-by":"crossref","first-page":"e1570","DOI":"10.1542\/peds.2007-2446","article-title":"Gluten intake interferes with the humoral immune response to recombinant hepatitis B vaccine in patients with celiac disease","volume":"121","author":"Nemes","year":"2008","journal-title":"Pediatrics"},{"key":"10.1016\/j.cgh.2023.03.025_bib13","doi-asserted-by":"crossref","first-page":"278","DOI":"10.3390\/vaccines8020278","article-title":"Vaccinations and immune response in celiac disease","volume":"8","author":"Passanisi","year":"2020","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.cgh.2023.03.025_bib14","first-page":"27","article-title":"Hepatitis B virus vaccination and revaccination response in children diagnosed with coeliac disease: a multicentre prospective study","volume":"82","author":"Rousseff","year":"2019","journal-title":"Acta Gastroenterol Belg"},{"key":"10.1016\/j.cgh.2023.03.025_bib15","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1097\/MPG.0b013e31827af200","article-title":"Response to hepatitis A and B vaccination in pediatric patients with celiac disease","volume":"56","author":"Urganci","year":"2013","journal-title":"J\u00a0Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.cgh.2023.03.025_bib16","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2015-3147","article-title":"Evidence-informed expert recommendations for the management of celiac disease in children","volume":"138","author":"Snyder","year":"2016","journal-title":"Pediatrics"},{"key":"10.1016\/j.cgh.2023.03.025_bib17","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1093\/ibd\/izx001","article-title":"Antibody response to hepatitis B virus vaccine is impaired in patients with inflammatory bowel disease on infliximab therapy","volume":"24","author":"Pratt","year":"2018","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.cgh.2023.03.025_bib18","article-title":"Safety and efficacy of infliximab in severe alcoholic hepatitis: a systematic review","volume":"11","author":"Majeed","year":"2019","journal-title":"Cureus"},{"key":"10.1016\/j.cgh.2023.03.025_bib19","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1111\/jgh.13001","article-title":"Treatment with infliximab or azathioprine negatively impact the efficacy of hepatitis B vaccine in inflammatory bowel disease patients","volume":"30","author":"Andrade","year":"2015","journal-title":"J\u00a0Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2023.03.025_bib20","doi-asserted-by":"crossref","first-page":"e940","DOI":"10.1097\/MD.0000000000000940","article-title":"Evaluation of factors associated with response to hepatitis B vaccination in patients with inflammatory bowel disease","volume":"94","author":"Cekic","year":"2015","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.cgh.2023.03.025_bib21","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1111\/jgh.12712","article-title":"Immunogenicity of hepatitis B vaccine in patients with inflammatory bowel disease and the benefits of revaccination","volume":"30","author":"Cossio-Gil","year":"2015","journal-title":"J\u00a0Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2023.03.025_bib22","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1038\/ajg.2012.79","article-title":"Efficacy of hepatitis B vaccination and revaccination and factors impacting on response in patients with inflammatory bowel disease","volume":"107","author":"Gisbert","year":"2012","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2023.03.025_bib23","doi-asserted-by":"crossref","first-page":"3065","DOI":"10.1016\/j.vaccine.2013.04.059","article-title":"Factors predicting response to hepatitis B vaccination in patients with inflammatory bowel disease","volume":"31","author":"Sempere","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.cgh.2023.03.025_bib24","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1007\/s00384-015-2383-7","article-title":"Hepatitis B virus vaccination failure in celiac disease and type 1 diabetes: what is the truth?","volume":"31","author":"Mormile","year":"2016","journal-title":"Int J Colorectal Dis"},{"key":"10.1016\/j.cgh.2023.03.025_bib25","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1097\/MPG.0000000000003362","article-title":"Celiac disease: risk of hepatitis B infection","volume":"74","author":"Habash","year":"2022","journal-title":"J\u00a0Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.cgh.2023.03.025_bib26","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1038\/ajg.2016.537","article-title":"ACG Clinical Guideline: preventive care in inflammatory bowel disease","volume":"112","author":"Farraye","year":"2017","journal-title":"Am J Gastroenterol"},{"issue":"Suppl 3","key":"10.1016\/j.cgh.2023.03.025_bib27","doi-asserted-by":"crossref","first-page":"s1","DOI":"10.1136\/gutjnl-2019-318484","article-title":"British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults","volume":"68","author":"Lamb","year":"2019","journal-title":"Gut"},{"key":"10.1016\/j.cgh.2023.03.025_bib28","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1053\/j.gastro.2021.04.034","article-title":"Canadian Association of Gastroenterology clinical practice guideline for immunizations in patients with inflammatory bowel disease (IBD)-Part 2: inactivated vaccines","volume":"161","author":"Jones","year":"2021","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2023.03.025_bib29","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1093\/ecco-jcc\/jjab052","article-title":"ECCO Guidelines on the prevention, diagnosis, and management of infections in inflammatory bowel disease","volume":"15","author":"Kucharzik","year":"2021","journal-title":"J\u00a0Crohns Colitis"},{"key":"10.1016\/j.cgh.2023.03.025_bib30","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1007\/s00535-021-01784-1","article-title":"Evidence-based clinical practice guidelines for inflammatory bowel disease 2020","volume":"56","author":"Nakase","year":"2021","journal-title":"J\u00a0Gastroenterol"},{"key":"10.1016\/j.cgh.2023.03.025_bib31","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1097\/MPG.0b013e31825959b8","article-title":"Health supervision in the management of children and adolescents with IBD: NASPGHAN recommendations","volume":"55","author":"Rufo","year":"2012","journal-title":"J\u00a0Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.cgh.2023.03.025_bib32","first-page":"1","article-title":"Prevalence and trends in hepatitis B virus infection in the United States, 2015-2018","author":"Kruszon-Moran","year":"2020","journal-title":"NCHS Data Brief"},{"key":"10.1016\/j.cgh.2023.03.025_bib33","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1093\/ije\/dys195","article-title":"Data resource profile: the Rochester Epidemiology Project (REP) medical records-linkage system","volume":"41","author":"St Sauver","year":"2012","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.cgh.2023.03.025_bib34","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.mayocp.2011.11.009","article-title":"Generalizability of epidemiological findings and public health decisions: an illustration from the Rochester Epidemiology Project","volume":"87","author":"St Sauver","year":"2012","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.cgh.2023.03.025_bib35","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1016\/j.mayocp.2012.08.012","article-title":"History of the Rochester Epidemiology Project: half a century of medical records linkage in a US population","volume":"87","author":"Rocca","year":"2012","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.cgh.2023.03.025_bib37","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/j.cgh.2016.10.039","article-title":"Incidence and prevalence of Crohn\u2019s disease and ulcerative colitis in Olmsted County, Minnesota from 1970 through 2010","volume":"15","author":"Shivashankar","year":"2017","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"7 Suppl","key":"10.1016\/j.cgh.2023.03.025_bib38","doi-asserted-by":"crossref","first-page":"S88","DOI":"10.1016\/S0016-5085(22)60224-5","article-title":"403: An update on inflammatory bowel disease epidemiology in Olmsted County, Minnesota from 1970 through 2019","volume":"162","author":"Bakhshi","year":"2022","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2023.03.025_bib39","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1007\/s10620-017-4835-0","article-title":"Gender-based differences in a population-based cohort with celiac disease: more alike than unalike","volume":"63","author":"Jansson-Knodell","year":"2018","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.cgh.2023.03.025_bib40","unstructured":"Bergstralh EJ, Kosanke JL. Computerized matching of cases to controls. 1995. Available at: https:\/\/www.mayo.edu\/research\/documents\/biostat-56pdf\/doc-10026923. Accessed November 13, 2023."},{"key":"10.1016\/j.cgh.2023.03.025_bib41","author":"Dean"},{"key":"10.1016\/j.cgh.2023.03.025_bib42","doi-asserted-by":"crossref","first-page":"6030","DOI":"10.1016\/j.vaccine.2009.07.099","article-title":"Hepatitis B vaccination failure in celiac disease: is there a need to reassess current immunization strategies?","volume":"27","author":"Leonardi","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.cgh.2023.03.025_bib43","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/S0264-410X(00)00224-3","article-title":"Lifelong protection against hepatitis B: the role of vaccine immunogenicity in immune memory","volume":"19","author":"Banatvala","year":"2000","journal-title":"Vaccine"},{"key":"10.1016\/j.cgh.2023.03.025_bib44","doi-asserted-by":"crossref","first-page":"6587","DOI":"10.1016\/j.vaccine.2008.09.034","article-title":"Twenty-two years follow-up of a prospective randomized trial of hepatitis B vaccines without booster dose in children: final report","volume":"26","author":"But","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.cgh.2023.03.025_bib45","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.vaccine.2005.08.058","article-title":"Hepatitis B surface antigen-specific T and B cell memory in individuals who had lost protective antibodies after hepatitis B vaccination","volume":"24","author":"Bauer","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.cgh.2023.03.025_bib46","doi-asserted-by":"crossref","DOI":"10.5812\/hepatmon.22223","article-title":"Long-term T-cell-mediated immunologic memory to hepatitis B vaccine in young adults following neonatal vaccination","volume":"14","author":"Saffar","year":"2014","journal-title":"Hepat Mon"},{"key":"10.1016\/j.cgh.2023.03.025_bib47","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1111\/jvh.13125","article-title":"Persistence of HBsAg-specific antibodies and immune memory two to three decades after hepatitis B vaccination in adults","volume":"26","author":"Van Damme","year":"2019","journal-title":"J\u00a0Viral Hepat"},{"key":"10.1016\/j.cgh.2023.03.025_bib48","doi-asserted-by":"crossref","first-page":"11273","DOI":"10.3748\/wjg.v21.i40.11273","article-title":"Immunogenicity and mechanisms impairing the response to vaccines in inflammatory bowel disease","volume":"21","author":"Marin","year":"2015","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.cgh.2023.03.025_bib49","doi-asserted-by":"crossref","first-page":"219","DOI":"10.3350\/cmh.2016.0024","article-title":"Prevention of hepatitis B reactivation in the setting of immunosuppression","volume":"22","author":"Pattullo","year":"2016","journal-title":"Clin Mol Hepatol"},{"key":"10.1016\/j.cgh.2023.03.025_bib50","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1080\/17474124.2020.1774364","article-title":"Hepatitis B reactivation: diagnosis and management","volume":"14","author":"Huang","year":"2020","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2023.03.025_bib51","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1136\/gut.2010.208413","article-title":"REPENTINA study; GETECCU (Grupo Espa\u00f1ol de Enfermedades de Crohn y Colitis Ulcerosa) Group. Liver dysfunction related to hepatitis\u00a0B and C in patients with inflammatory bowel disease treated with immunosuppressive therapy","volume":"59","author":"Loras","year":"2010","journal-title":"Gut"},{"key":"10.1016\/j.cgh.2023.03.025_bib52","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1097\/MD.0b013e3182380a76","article-title":"Hepatitis B virus (HBV) reactivation in patients receiving tumor necrosis factor (TNF)-targeted therapy: analysis of 257 cases","volume":"90","author":"Perez-Alvarez","year":"2011","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.cgh.2023.03.025_bib53","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1002\/ibd.22905","article-title":"Clinical courses of chronic hepatitis B virus infection and inflammatory bowel disease in patients with both diseases","volume":"18","author":"Park","year":"2012","journal-title":"Inflamm Bowel Dis"}],"container-title":["Clinical Gastroenterology and Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542356523002331?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542356523002331?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T05:44:52Z","timestamp":1761543892000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1542356523002331"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":52,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["S1542356523002331"],"URL":"https:\/\/doi.org\/10.1016\/j.cgh.2023.03.025","relation":{},"ISSN":["1542-3565"],"issn-type":[{"value":"1542-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effectiveness of Hepatitis B Vaccination for Patients With Inflammatory Bowel and Celiac Disease","name":"articletitle","label":"Article Title"},{"value":"Clinical Gastroenterology and Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cgh.2023.03.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 by the AGA Institute","name":"copyright","label":"Copyright"}]}}